Favipiravir
Cipla Set to Launch Repurposed Drug Favipiravir for COVID-19
Cipla has scaled up the process in their manufacturing facility and approached Drug Controller General of India (DCGI) for permission… Read More
Containing the Deadly COVID-19: Viability of Pooling Technologies
Global pandemic COVID-19 is now in 199 countries with reported confirmed cases above two million and mounting death tolls in… Read More